Vera Belyakova (V V Belyakova)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 2

Top Topics

Prognostic Factors

Randomized Controlled Trial

Ejection Fraction

Chronic Lymphocytic Leukemia

Top Venues

Klinicheskaia laboratornaia diagnostika

This page only lists publications with an associated author ORCID identifier.

Publications

Eugene A Nikitin, Maria Kislova, Dmitry Morozov, Vera Belyakova, Anna Suvorova, Julia Sveshnikova, Galina Vyscub, Irina Matveeva, Maria Shirokova, Anna Shipaeva, Tatyana Klitochenko, Polina Makarovskaya, Elena A Dmitrieva, Bella Biderman, Andrey Borisovich Sudarikov, Tatiana N Obukhova, Olga Samoilova, Kamil Kaplanov, Tatyana Konstantinova, Olga Mayorova, Irina Poddubnaya, Vadim V Ptushkin
Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias. Leukemia (2023)
Sergey Ivanovich Donskov, Andrey Y Bulanov, I B Simarova, Vera Belyakova, Olga Mayorova, E A Kravtsova, I O Vakulchik, T Yu Yurkevich, M V Beluga, L M Zubareva, N M Mikhailova, N I Vasiliev, L E Davydova, Yu V Burdinskaya, S B Kryukovskiy
AB0 and rhesus blood groups as a risk factor for ARVI COVID-19. Klinicheskaia laboratornaia diagnostika 66 (11) (2021)